Hims & Hers shares fall after FDA says semaglutide no longer in shortage

Hims & Hers shares fall after FDA says semaglutide no longer in shortage

Shares of Hims & Hers Health closed down around 26% on Friday after the U.S. Food…

Continue Reading
Hims & Hers faces lawmaker scrutiny over 'misleading' Super Bowl ad

Hims & Hers faces lawmaker scrutiny over ‘misleading’ Super Bowl ad

Hims & Hers is facing scrutiny from lawmakers over an advertisement for its weight loss offerings…

Continue Reading
Stocks making the biggest moves midday: TXN, GRND, TWLO

Stocks making the biggest moves midday: TXN, GRND, TWLO

Check out the companies making headlines in midday trading: Verizon Communications — The telecommunications giant saw…

Continue Reading
GLP-1s, Brian Thomson killing loom large at JPM Health

GLP-1s, Brian Thomson killing loom large at JPM Health

Jamie Dimon, chief executive officer of JPMorgan Chase & Co., at the Institute of International Finance…

Continue Reading
Stocks making the biggest moves midday: NVO, QRVO, JBHT

Stocks making the biggest moves midday: NVO, QRVO, JBHT

Check out the companies making headlines in midday trading. Crypto stocks – Stocks tied to crypto…

Continue Reading
Eli Lilly invests to increase Mounjaro, Zepbound supply

FDA Zepbound shortage ends, impacts patients, compounding pharmacies

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City…

Continue Reading
Stocks, economic data, business news

Stocks, economic data, business news

European stocks closed higher on Friday, as regional markets reopened following a closure for the Christmas…

Continue Reading
stocks, news, data and earnings

stocks, news, data and earnings

The entrance of the London Stock Exchange Group building on Dec. 8, 2024. Manuel Romano |…

Continue Reading
Digital health stocks pummeled by Wall Street in 2024, but Hims surges

Digital health stocks pummeled by Wall Street in 2024, but Hims surges

Doximity at the New York Stock Exchange for their IPO, June 24, 2021. Source: NYSE If…

Continue Reading
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea

FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York,…

Continue Reading